OTCMKTS:IRCLF

InterCure (IRCLF) Stock Price, News & Analysis

InterCure logo

About InterCure Stock (OTCMKTS:IRCLF)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
9,400 shs
Average Volume
9,097 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

InterCure Ltd. is an Israeli medical cannabis company that operates under the Canndoc brand. Its business includes the cultivation, processing, manufacturing and distribution of cannabis products for medical use, such as dried flower and related formulations.

The company serves Israel’s regulated medical cannabis market and has pursued international sales and partnerships in markets including Europe and Australia, subject to local regulations.

Founded in 2008, InterCure expanded into the cannabis sector through its acquisition of Canndoc in 2018.

AI Generated. May Contain Errors.

Receive IRCLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InterCure and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IRCLF Stock News Headlines

Beschreibung der Geschäftstätigkeit: InterCure Ltd.
I'm handing you this stock today
Elon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.tc pixel
InterCure Regains Nasdaq Compliance
INCR Stock Split History
See More Headlines

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:IRCLF
CIK
N/A
Fax
N/A
Employees
75
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (OTCMKTS:IRCLF) was last updated on 8/31/2021 by MarketBeat.com Staff.
From Our Partners